Making a difference, patient by patient

US WorldMeds is a specialty pharmaceutical company that develops, licenses, and brings to market unique healthcare products designed to improve the lives of patients with challenging conditions and unmet medical needs

Patients are key to everything that we do at US WorldMeds


We will create a sustainable, privately held specialty pharmaceutical company.


We will market meaningful products that improve lives and result in a thriving community of patients, employees and shareholders.


We will embrace a culture that values honesty, creativity and action, integrity in relationships, a passion for success and good stewardship of Company resources.

Our people bring US WorldMeds to life

The leadership team at US WorldMeds

Paul Breckinridge "Breck" Jones
Chief Executive Officer

Founder and Member of the Board of Directors since March 2001

H. Lee Warren, Jr
Chief Operating Officer

Over 25 years of experience in Pharmaceutical Operations, Sales Management, Marketing and National Accounts

George Digenis, PhD
Chief Scientific Officer

Professor Emeritus of Medicinal Chemistry at University of Kentucky College of Pharmacy

Henry van den Berg, MD
Senior Vice President

25 years of experience in Medical Affairs and Marketing

Stephanie Montgomery, SPHR
Vice President, Finance

20 years of experience in Operational Accounting, Finance and Development, Human Resources and IT

Brian Jackey
Vice President, Global Operations and Quality

Over 20 years of experience in Manufacturing Operations

Gary Grote
Vice President, Market Access

Over 35 years in the pharmaceutical industry, with over 20 years of experience in managed care

Kristen Gullo
Vice President, Development and Regulatory Affairs

Over 10 years of experience in Pharmaceutical Development Strategy, Clinical Operations and Regulatory Affairs

Brandon King
Director, Marketing

Over 15 years of experience in Pharmaceutical Marketing, Business Development, Sales, and Brand Management